Company Data

iTeos Therapeutics Inc.

Ticker
ITOS
Current Price
$10 -0.3%
Market Cap
$382.7M
Price Target
Refer to Report
Volume
1.3M
52wk Range
$4.8 - $18.13
Advanced Market Data

Overview

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy